LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel: Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Payne, Rebecca P. / Longet, Stephanie / Austin, James A. / Skelly, Donal T. / Dejnirattisai, Wanwisa / Adele, Sandra / Meardon, Naomi / Faustini, Sian / Al-Taei, Saly / Moore, Shona C. / Tipton, Tom / Hering, Luisa M. / Angyal, Adrienn / Brown, Rebecca / Nicols, Alexander R. / Gillson, Natalie / Dobson, Susan L. / Amini, Ali / Supasa, Piyada /
Cross, Andrew / Bridges-Webb, Alice / Reyes, Laura Silva / Linder, Aline / Sandhar, Gurjinder / Kilby, Jonathan A. / Tyerman, Jessica K. / Altmann, Thomas / Hornsby, Hailey / Whitham, Rachel / Phillips, Eloise / Malone, Tom / Hargreaves, Alexander / Shields, Adrian / Saei, Ayoub / Foulkes, Sarah / Stafford, Lizzie / Johnson, Sile / Wootton, Daniel G. / Conlon, Christopher P. / Jeffery, Katie / Matthews, Philippa C. / Frater, John / Deeks, Alexandra S. / Pollard, Andrew J. / Brown, Anthony / Rowland-Jones, Sarah L. / Mongkolsapaya, Juthathip / Barnes, Eleanor / Hopkins, Susan / Hall, Victoria / Dold, Christina / Duncan, Christopher J.A. / Richter, Alex / Carroll, Miles / Screaton, Gavin / de Silva, Thushan I. / Turtle, Lance / Klenerman, Paul / Dunachie, Susanna / Abuelgasim, Hibatullah / Adland, Emily / Adlou, Syed / Akther, Hossain Delowar / Alhussni, Ahmed / Ali, Mohammad / Ansari, M. Azim / Arancibia-Cárcamo, Carolina V. / Bayley, Martin / Brown, Helen / Chalk, Jeremy / Chand, Meera / Chawla, Anu / Chinnakannan, Senthil / Cutteridge, Jospeh / de Lara, Catherine / Denly, Lucy / Diffey, Ben / Dimitriadis, Stavros / Drake, Thomas M. / Donnison, Timothy / Dupont, Maeva / Eyre, David / Fairman, Alex / Gardiner, Siobhan / Gilbert-Jarmillo, Javier / Goulder, Philip / Hackstein, Carl-Philipp / Hambleton, Sophie / Haniffa, Muzlifah / Haworth, Jenny / Holmes, Jennifer / Horner, Emily / Jämsén, Anni / Jones, Chris / Kasanyinga, Mwila / Kelly, Sinead / Kirk, Rosemary / Knight, Michael L. / Lawrie, Allan / Lee, Lian / Lett, Lauren / Lillie, Katy / Lim, Nicholas / Mehta, Hema / Mentzer, Alexander J. / O’Donnell, Denise / Ogbe, Ane / Pace, Matthew / Payne, Brendan A.I. / Platt, Gareth / Poolan, Sonia / Provine, Nicholas / Ramamurthy, Narayan / Robinson, Nichola / Romaniuk, Leigh / Rongkard, Patpong / Sampson, Oliver L. / Simmons, Beatrice / Spegarova, Jarmila S. / Stephenson, Emily / Subramaniam, Kris / Thaventhiran, James / Thomas, Sarah / Travis, Simon / Tucker, Stephanie / Turton, Helena / Watson, Adam / Watson, Lisa / Weeks, Esme / Wilson, Robert / Wood, Steven / Wright, Rachel / Xiao, Huiyuan / Zawia, Amira A.T.

Cell. 2021 Nov. 11, v. 184, no. 23

2021  

Abstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United ... ...

Körperschaft on behalf of the PITCH Consortium
Abstract Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers. The first vaccine dose induced protection from infection from the circulating alpha (B.1.1.7) variant over several weeks. In a substudy of 589 individuals, we show that this single dose induces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (NAb) responses and a sustained B and T cell response to the spike protein. NAb levels were higher after the extended dosing interval (6–14 weeks) compared with the conventional 3- to 4-week regimen, accompanied by enrichment of CD4⁺ T cells expressing interleukin-2 (IL-2). Prior SARS-CoV-2 infection amplified and accelerated the response. These data on dynamic cellular and humoral responses indicate that extension of the dosing interval is an effective immunogenic protocol.
Schlagwörter Severe acute respiratory syndrome coronavirus 2 ; health services ; immunogenicity ; interleukin-2 ; vaccines ; United Kingdom
Sprache Englisch
Erscheinungsverlauf 2021-1111
Umfang p. 5699-5714.e11.
Erscheinungsort Elsevier Inc.
Dokumenttyp Artikel
ZDB-ID 187009-9
ISSN 1097-4172 ; 0092-8674
ISSN (online) 1097-4172
ISSN 0092-8674
DOI 10.1016/j.cell.2021.10.011
Signatur
Z 75/702: Hefte anzeigen
Z 93: Hefte anzeigen
Datenquelle NAL Katalog (AGRICOLA)

Zusatzmaterialien

Kategorien

Zum Seitenanfang